Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02098694
Other study ID # 2013/1520 (REK)
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 2014
Est. completion date April 2015

Study information

Verified date June 2020
Source Norwegian University of Science and Technology
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether patients with spondyloarthritis are more satisfied with a physiotherapy-led outpatient clinic than usual care and whether there is a difference between patients in a physiotherapy-led outpatient clinic and those in usual care regarding disease activity, function and mobility.


Recruitment information / eligibility

Status Completed
Enrollment 62
Est. completion date April 2015
Est. primary completion date April 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- confirmed diagnosis spondyloarthritis, ankylosing spondylitis, spondylarthropathy, juvenile ankylosing spondylitis, psoriatic arthritis with affection of the spine

- age between 18 and 45 (born 1969 - 1996)

Exclusion Criteria:

- also diagnosed with potentially functionally impairing neuromuscular, neurological or muscular disorders

- insufficient Norwegian language skills

- cognitive impairment

- no sign of inflammation or bone erosions in the sacroiliac joints or in the spine on imaging

Study Design


Intervention

Other:
Physiotherapy follow-up
Physiotherapy consultation every 4 months containing assessment of the spine and its mobility, including axial joints, assessment of the patients activity profile. Instruction in home-exercises and recommendations for optimization of activity profile. Information regarding the disease and the importance of physical activity and exercise.

Locations

Country Name City State
Norway Department of Rheumatology, Ålesund hospital Ålesund

Sponsors (2)

Lead Sponsor Collaborator
Norwegian University of Science and Technology Helse Møre og Romsdal HF

Country where clinical trial is conducted

Norway, 

References & Publications (1)

Holøyen PK, Stensdotter AK. Patients with spondyloarthritis are equally satisfied with follow-up by physiotherapist and rheumatologist. Musculoskeletal Care. 2018 Sep;16(3):388-397. doi: 10.1002/msc.1241. Epub 2018 Mar 24. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Leeds Patient Satisfaction Questionnaire (LSQ) 8 months
Secondary Bath Ankylosing Spondylitis Metrology Index (BASMI) 8 months
Secondary Bath Ankylosing Spondylitis Functional Index (BASFI) 8 months
Secondary Ankylosing Spondylitis Disease Activity Score (ASDAS) 8 months
See also
  Status Clinical Trial Phase
Completed NCT02181673 - A Study of Golimumab in Participants With Active Psoriatic Arthritis Phase 3
Recruiting NCT04936308 - Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent Phase 3
Terminated NCT00090129 - Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis Phase 3
Withdrawn NCT03625089 - Impact of Nurse-led Programme With Carotid Ultrasound on Addressing Cardiovascular Risk in Patients With Arthritis N/A
Recruiting NCT05571696 - Mind Matters: A High Touch, Low Cost Approach to Improving Mental Health Outcomes in Patients With Psoriatic Diseases N/A
Active, not recruiting NCT05071664 - A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis Phase 2
Completed NCT00938015 - Study Evaluating Safety and Adherence to Treatment With Etanercept in Adults With Psoriatic Arthritis N/A
Suspended NCT03703934 - Central Pain Mechanisms in Patients With Hand-Osteoarthritis, Psoriatic Arthritis and Healthy Controls
Recruiting NCT05092269 - A Long-term Extension Study of Ustekinumab in Pediatric Participants Phase 3
Terminated NCT05083078 - A Study of Guselkumab and Risankizumab in Healthy Participants and Participants With Psoriatic Arthritis Phase 1
Completed NCT02436785 - Do Inflammatory Arthritis Inpatients Receiving Group Music Therapy Improve Pain Compared to Music Listening? N/A
Completed NCT02294227 - 16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic Arthritis Phase 3
Completed NCT00998829 - Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque Psoriasis N/A
Completed NCT00760669 - An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants Phase 4
Completed NCT00367237 - Remicade Study in Psoriatic Arthritis Patients Of Methotrexate-Naïve Disease (RESPOND) (Study P04422) Phase 3
Completed NCT00051623 - A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic Arthritis Phase 3
Withdrawn NCT04680676 - A Study to Test Different Doses of BI 730357 and Find Out Whether They Reduce Symptoms in People With Active Psoriatic Arthritis Phase 2
Completed NCT03008590 - Low Dose Naltrexone for Chronic Pain From Arthritis Phase 2
Recruiting NCT05657847 - Novel Complex Radiodiagnostics of Peripherial Arthropathies
Completed NCT02875184 - A Study of Apremilast Use and Effectiveness in Patients With Psoriatic Arthritis in The Netherlands